Blood exposure awareness

Proactively protect against blood exposure

Approximately 90% of hospitalized patients require IV therapy,1 and peripheral IV catheter insertion is the most commonly performed invasive procedure in hospitals2—but it can present a significant amount of blood. Though devices and practices promoting needlestick safety can help prevent exposure to blood, clinicians should be aware of other ways to protect themselves from the risks. BD provides information that can help provide this protection.

Personal stories

Watch the following stories from healthcare personnel who have been exposed to blood while inserting IVs:

Cheryll Collins, RN

Registered nurse Cheryll Collins shares how her life changed after being exposed to HIV-infected blood while performing a peripheral IV catheter insertion. She also explains how she approaches IV insertion differently now and what clinicians can do to better protect themselves from contaminated blood.

Edie, RN

Edie, an emergency/trauma nurse, shares how her friend and coworker was infected with HIV after being exposed to just a few drops of blood. She was a nurse for 25 years—adamant about using universal precautions—but one split-second decision changed her career, and her life. Edie shares her story in hopes to prevent this from happening to other nurses.

Industry standard

According to the Occupational Safety & Health Administration (OSHA) Enforcement Procedures for the Occupational Exposure to Bloodborne Pathogens, "The employer must use engineering and work practice controls that eliminate occupational exposure or reduce it to the lowest feasible extent."3

Read the OSHA instruction

Articles/Reports

Review the following articles and published research on blood exposure:

Nursing 2011 survey results on blood exposure risk


A 2011 study published in Nursing shows that the rate of at-risk blood exposure for IV catheter insertions is 128 per 100,000 insertions (the combined rate of blood contact to the eyes, nose, mouth and nonintact skin).4

View the full story

Workers risking injury by not wearing personal protective equipment


Nearly all of the safety professionals in a survey said that workers in their organization had, at some point, failed to wear the necessary safety equipment while on the job.5

View the full story

A 2011 EPINet™ report on blood and body fluid exposures


The 2011 EPINet report "Blood and body fluid exposures" includes the following statistics:

  • The average blood and bodily fluid exposure rate was 7.23 per 100 occupied beds, with 44.3% of exposures to nurses.6
  • 83.7% of exposures involved unprotected skin.6
  • 76.6% of exposures involved the head or face.6

View the full story

A CDC report


The Centers for Disease Control and Prevention (CDC) reports the following statistics related to HIV and Hepatitis C virus (HCV):

  • At the end of 2009, an estimated 1,148,200 persons in the United States were living with HIV infection, with 18.1% undiagnosed.7
  • As of 2006-2007, 3.2 million persons in the United States alone have chronic HCV infection.8

View the full story

Product portfolio of safety solutions

BD has developed innovative technologies that specifically address safety and blood containment in IV catheter settings. Our product portfolio includes peripheral IV catheters designed to protect clinicians as well as patients.

This portfolio includes the following products:

  • The BD Nexiva™ closed IV catheter system has been shown to significantly reduce blood exposure during insertion,9* minimizing the potential for contamination and exposure to bloodborne pathogens. 
  • The BD Insyte™ Autoguard™ BC shielded IV catheter with blood control technology is clinically demonstrated to reduce the risk of blood exposure by 95%.10†

BD Nexiva™ closed IV catheter system

The BD Nexiva closed IV catheter system is an all-in-one closed system IV catheter designed to last throughout the treatment process.

BD Nexiva™ Diffusics™ closed IV catheter system

The BD Nexiva Diffusics closed IV catheter system is designed to address common CT IV challenges.

BD Insyte™ Autoguard™ BC shielded IV catheter with blood control technology

The BD Insyte Autoguard BC shielded IV catheter with blood control technology promotes safety and performance by reducing the risk of blood exposure and providing other benefits.


 

"Blood control and blood-contained safety peripheral intravenous cannulas (SPICVs) do not require clinicians to occlude the vessel during insertion. Ultimately, they reduce cleanup costs, nursing time and any additional costs should an exposure occur."11


Notes

* Compared to an open system
† Compared to a non-blood control IV catheter

References
  1. iData Research. U.S. vascular access devices and market - 2014. Published 2015.
  2. Mestre G, Berbel C, Tortajada P, et al. Successful multifaceted intervention aimed to reduce short peripheral venous catheter-related adverse events: a quasiexperimental cohort study. Am J Infect Control. 2013;41(6):520-526.
  3. Occupational Safety & Health Administration. Enforcement Procedures for the Occupational Exposure to Bloodborne Pathogens. https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=DIRECTIVES&p_id=2570. Published November 27, 2001. Accessed October 3, 2015.
  4. Jagger J, Perry J, Parker G, et al. Blood exposure risk during IV catheter insertion and removal. Nursing. 2011;41(12):45-49.
  5. Workers risking injury by not wearing PPE. Infection Control Today. 2010. http://www.infectioncontroltoday.com/news/2010/08/workers-risking-injury-by-not-wearing-ppe.aspx.
  6. University of Virginia Health System. 2011 EPINet report: Blood and body fluid exposures. http://www.healthsystem.virginia.edu/pub/epinet/EPINet2011-BBFexposureRpt-revised.pdf. Published 2011. Accessed April 22, 2014.
  7. Centers for Disease Control and Prevention. HIV Surveillance Report. http://www.cdc.gov/hiv/statistics/basics/index.html. Published 2011.
  8. Klevens RM, Miller J, Vonderwahl C, et al. Population-based surveillance for Hepatitis C virus, United States, 2006–2007. Emerg Infect Dis. 2009;15(9). doi: 10.3201/eid1509.081050.
  9. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371-384.
  10. Onia R, Eshun-Wilson I, Arce C, et al. Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. Curr Med Res Opin. 2011;27(7):1339-1346.
  11. Richardson D, Kaufman L. Reducing blood exposure risks and costs associated with SPIVC insertion. Nurs Manage. 2011;42(12):31-34.

BD-1908 (03/17)